Galapagos - In Darwin’s footsteps: exploring the role of JAK inhibitors within the diverging RA treatment landscape


Industry room 4
English
Satellite Symposia
03 June 2021 17:30 - 19:00

Learning Objectives:

  • Describe the chronic and evolving state of disease in rheumatoid arthritis (RA) and how poorly controlled disease affects the daily lives of patients
  • Evaluate the efficacy and safety profiles of available treatment options and highlight how the right treatment can positively impact patients’ daily lives
  • Summarise the efficacy and safety profile of filgotinib
  • Explain how treatment mechanism of action may translate to different efficacy and safety profiles


Presentations

Title Time Calendar .ics
Welcome and introduction
03 June 2021 17:30 - 17:35 .ics
Through the looking glass: living with rheumatoid arthritis
03 June 2021 17:35 - 17:40 .ics
Great expectations: translating clinical features of different treatments to meet patient needs
03 June 2021 17:40 - 18:05 .ics
Brave new world: exploring the impact of treatment evolutions
03 June 2021 18:05 - 18:15 .ics
Panel discussion and Q&A
03 June 2021 18:15 - 18:30 .ics